ctrl K

Watchlist Price Alert

ALX Oncology Inc. (ALXO)

NASDAQ: ALXO · Real-Time Price · USD

0.49

-0.04 (-7.83%)

At close: Jun 17, 2025, 3:59 PM

ALX Oncology Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	n/a	1.18M	4.8M	2.07M
Cost of Revenue	n/a	836K	1.47M	736K	1.07M	4.36M	1.88M
Gross Profit	n/a	-836K	-1.47M	-736K	107K	436K	187K
Operating Income	-142.47M	-170.28M	-127.44M	-83.56M	-43.66M	-19.18M	-13.68M
Interest Income	9.37M	10.65M	4.04M	91.00	124K	21.00	n/a
Pretax Income	-134.85M	-160.81M	-123.42M	-83.48M	-45.5M	-19.21M	-13.69M
Net Income	-134.85M	-160.81M	-123.48M	-83.46M	-45.74M	-19.24M	-13.73M
Selling & General & Admin	26.09M	28.48M	29.04M	23.39M	14.81M	3.31M	2.6M
Research & Development	116.37M	141.79M	98.4M	60.17M	28.96M	16.31M	11.27M
Other Expenses	n/a	n/a	-260K	84K	-404K	-5K	-2K
Operating Expenses	142.47M	170.28M	127.44M	83.56M	43.77M	19.62M	13.87M
Interest Expense	1.73M	1.56M	n/a	13K	811K	21K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	142.47M	170.28M	127.44M	83.56M	44.84M	23.98M	15.75M
Income Tax Expense	n/a	n/a	64K	-21K	241K	34K	45K
Shares Outstanding (Basic)	52.17M	42.99M	40.7M	40.31M	39.84M	36.49M	21.95M
Shares Outstanding (Diluted)	52.17M	42.99M	40.7M	40.31M	39.84M	36.49M	21.95M
EPS (Basic)	-2.58	-3.74	-3.03	-2.07	-1.15	-0.53	-0.63
EPS (Diluted)	-2.58	-3.74	-3.03	-2.07	-1.15	-0.53	-0.63
EBITDA	-132.25M	-158.4M	-121.95M	-83.47M	-43.46M	-18.76M	-13.26M
EBIT	-133.12M	-159.24M	-123.42M	-83.47M	-43.66M	-19.19M	-13.69M
Depreciation & Amortization	872K	836K	1.47M	736K	202K	429K	431K